AACR

The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.

[AACR @AACR]

AACR is deeply concerned that proposed OMB regulations would disrupt the process for awarding federal research grants, severely weakening a program that has supported American medical innovation for decades. Learn more: https://t.co/qGrx9EhbAm
#UnitedByCancerResearch

[AACR @AACR]

Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes.
https://t.co/8tJ8M6p3at
#AACRpan26 @MadameSurgeon

[AACR @AACR]

Cancer researchers explain how certain provisions of the White House Office of Management and Budget’s proposal to change how federal grants are managed will undermine U.S. scientific innovation. Learn more on the #AACRBlog: https://t.co/nryDpuTEB3

[AACR @AACR]

Sharing your cancer diagnosis with someone can be stressful, especially if it's someone you recently started dating. @CancerTodayMag asked a social worker for advice on how to have that conversation: https://t.co/SghLk1smjU

[AACR @AACR]

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
https://t.co/HSV5pEpD5a
#SABCS26

[AACR @AACR]

The @US_FDA extends a prior approval for pembrolizumab (or pembrolizumab and berahyaluronidase alfa-pmp) with enfortumab vedotin-ejfv both before and after cystectomy to include all adults with muscle-invasive bladder cancer eligible for surgery: https://t.co/iZ0ngfci0d

[AACR @AACR]

The @US_FDA approved a subcutaneously delivered formulation of the targeted therapy isatuximab-irfc in combination with other drugs for three indications to treat certain adults with newly diagnosed or previously treated multiple myeloma: https://t.co/DRIF7DgJJr

[AACR @AACR]

Submit an abstract by July 23 for the AACR Conference on The Science of Cancer Health Disparities (Oct 18-21; Atlanta), chaired by Iona Cheng, Melissa Davis, Carmen Guerra, Kimberly Richardson, and Enrique Velazquez Villareal.
https://t.co/Wxru60s8go
#AACRdisp26 #AACRMICR

[AACR @AACR]

Join us today at 11:30 AM ET for an AACR webinar on Connecting, Collaborating, and Advancing Your Research Career, moderated by Roy Herbst and featuring Elizabeth Platz, Bora Lim, and Mark E. Hatley. Learn more:
https://t.co/l9BmEMaa3j
@hatleylab

[AACR @AACR]

Chris Baccash shares how surviving cancer led him to pursue a life of helping others, including by participating in the upcoming Philadelphia Cycling Classic Charity Ride for AACR. Learn more on the #AACRBlog: https://t.co/atfNpXBEY7 #RidersForResearch

[AACR @AACR]

To nurture the next generation of cancer researchers, the AACR offers programs for high school and undergraduate students. Learn about these educational opportunities for aspiring scientists in the latest issue of Leading Discoveries: https://t.co/HlGYEXGXcp

[AACR @AACR]

Submit an abstract by July 9 for the AACR Special Conference on Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more:
https://t.co/v52eYJG7fM
#AACRpediatric26 @DrAnnieHuang

[AACR @AACR]

.@FDA_Oncology expanded treatment options for cancers of the breast, prostate, urinary system, blood, and more during the second quarter of 2026. Learn how these new approvals fit into the therapeutic landscape on the #AACRBlog: https://t.co/4kizoV5tAC

[AACR @AACR]

How to Write a Competitive Proposal While Avoiding Pitfalls:
Oliver Bogler will address this topic during the AACR webinar on Strategies for Securing Non-Federal Funding (Friday, July 10; 11:30 AM-1:30 PM ET). Learn more:
https://t.co/9NS0Eyb2xt

[AACR @AACR]

#AACR26 session recordings are still available to meeting registrants for on-demand viewing through Saturday, October 31. Registration is also open until Wednesday, September 30 for new users who wish to purchase access to these recordings. Learn more:
https://t.co/eeTJ2Bt6Mz

[AACR @AACR]

Long-standing inequities in numerous social determinants of health contribute to significant disparities in the burden of preventable cancer risk factors. Learn more in the AACR Cancer Disparities Progress Report: https://t.co/GnwGSzjMRq

[AACR @AACR]

The proposed OMB rule puts politics over science, allowing non-expert political appointees to override merit-based grant decisions. Act now to protect scientific integrity by submitting your comments and contacting Congress. https://t.co/IezBhKayyc #UnitedByCancerResearch

[AACR @AACR]

Submit an abstract by July 8 for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (November 18-20; Barcelona, Spain), chaired by Elena Garralda, Ryan Corcoran, and Tim Greten. Learn more:
https://t.co/cg5JZwjNUg
@EORTC @theNCI

[AACR @AACR]

Joseph F. Fraumeni, Jr., MD, FAACR, a renowned cancer epidemiologist, a Fellow of the AACR Academy, and a former member of the AACR Board of Directors, died June 22, 2026, at the age of 93. We offer condolences to his family, friends, and colleagues. https://t.co/oabygTfxLE

[AACR @AACR]

Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes.
https://t.co/WdKlta3lHb
#AACRpan26 @EileenMOReilly

[AACR @AACR]

The AACR congratulates the advocates and Scientist ↔ Survivor Program (SSP) graduates recognized in OncoDaily’s 100 Influential Cancer Survivors on Social Media: 2026 Edition. These survivors have transformed their experiences into advocacy. https://t.co/msKFfXJOGN. #AACRSSP